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Background: Sleep is disrupted in depressed subjects, but it also deteriorates with age and possibly with the transition
to menopause. The nature of interaction between mood, sleep, age and reproductive state is not well-defined. The aim
of this study was to evaluate the relationship between mood and sleep among healthy women in different reproductive
states.
Methods: We analyzed data from 11 younger (20–26 years), 21 perimenopausal (43–51 years) and 29 postmenopausal
(58–71 years) healthy women who participated in a study on menopause, sleep and cognition. The 21-item Beck
Depression Inventory (BDI) was administered to assess mood. Subjective sleep quality was assessed with the Basic
Nordic Sleep Questionnaire (BNSQ). Objective sleep was measured with all-night polysomnography (PSG) recordings.
Perimenopausal and younger women were examined during the first days of their menstrual cycle at the follicular
phase.
Results: Among younger women, less arousals associated with higher BDI total scores (p = 0.026), and higher SWS
percentages with more dissatisfaction (p = 0.001) and depressive-somatic symptoms (p = 0.025), but with less
depressive-emotional symptoms (p = 0.001). In specific, less awakenings either from REM sleep or SWS, respectively,
associated with more punishment (p = 0.005; p = 0.036), more dissatisfaction (p < 0.001; p = 0.001) and more
depressive-somatic symptoms (p = 0.001; p = 0.009), but with less depressive-emotional symptoms (p = 0.002; p = 0.003).
In perimenopausal women, higher BNSQ insomnia scores (p = 0.005), lower sleep efficiencies (p = 0.022) and shorter
total sleep times (p = 0.024) associated with higher BDI scores, longer sleep latencies with more depressive-somatic
symptoms (p = 0.032) and longer REM latencies with more dissatisfaction (p = 0.017). In postmenopausal women,
higher REM percentages associated with higher BDI total scores (p = 0.019) and more depressive-somatic symptoms
(p = 0.005), and longer SWS latencies with more depressive-somatic symptoms (p = 0.030).
Conclusions: Depressive symptoms measured with the total BDI scores associated with sleep impairment in both
perimenopausal and postmenopausal women. In younger women, specific BDI factors revealed minor associations,
suggesting that the type of sleep impairment can vary in relation to different depressive features. Our data indicate
that associations between sleep and depressed mood may change in conjunction with hormonal milestones.
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Depressive symptoms are more common in women than
in men [1,2]. Mood disorders, and in particular major
depressive disorder (MDD), are also known to be twice
as common in women as in men [3]. In addition, the on-
set, course and symptoms of depression differ between
genders, as women are more likely to suffer from atyp-
ical depression, psychomotor retardation, anxiety/som-
atic symptoms, psychological distress, increased appetite
and weight gain than men [2-6].
Although this gender difference persists throughout
the female life-span, it seems to vary according to the re-
productive state. The risk of depressive symptoms and
that of disorders are higher during certain reproductive
events such as the premenstrual phase, pregnancy and
postpartum [7], and the transition to menopause [8,9].
In particular, during the climacterium there is an in-
creased risk of experiencing low mood, irritability and
difficulties in concentration, even after controlling for
possible confounding factors [10-12], and up to 70–90%
of women report depressive symptoms [13].
Depressive symptoms and disorders are often accom-
panied by sleep disturbances. Indeed, sleep is typically
disrupted in depressed subjects, with an abnormal
amount and/or an abnormal distribution of rapid-eye-
movement (REM) sleep and non-REM sleep [14], older
individuals being more likely to suffer from middle or
late insomnia and younger ones from hypersomnia
[15-17]. Sleep impairment has been claimed as a pro-
dromal symptom of depression, and some sleep abnor-
malities are considered as specific markers for MDD,
such as impairment in sleep continuity, a lack of inhib-
ition of REM sleep, and reduction in slow-wave sleep
(SWS) [14,18]. Reciprocally, subjects suffering from in-
somnia or other sleep disturbances seem to be at a
higher risk of developing MDD [19] and having recur-
rent depressive episodes [20]. However, whether sleep
disturbances are part of the pathophysiology of depres-
sion or its consequences, it is not well understood
[21,22]. Possibly, sleep disturbances and other psychi-
atric disorders share a common multifactorial etiology
here [23].
Age and fluctuations of female sex hormones are likely
to be part of this multifactorial etiology. Age is associ-
ated with a reduction of REM sleep and SWS [24-26],
with an increase in time spent in lighter sleep stages and
a general decrease in sleep efficiency especially in
women [27]. On the other hand, aging is tightly inter-
related with the transition to menopause, which in turn
is characterized by an intense decrease of sex hormone
levels. Women do commonly report sleep difficulties
with an impaired subjective sleep quality and, to a lesser
extent, also an impaired objective sleep quality during
perimenopause and in postmenopause [28-32]. Recently,Orff and colleagues [33] found that age and the repro-
ductive status affect a different set of objective sleep pa-
rameters in women. One important study to focus on
the relationship between reproductive state, sex hor-
mone levels, sleep and depression [34], came to the con-
clusion that the association between hormonal changes
and menopause could contribute to the increase in the
sleep-endocrine alterations that are typically found in
depression.
Given the complexity of the inter-relationship between
mood, sleep, age and reproductive state, and the lack of
clear evidence on this issue, the aim of our study was to
evaluate the relationship between mood and sleep
among healthy women in different reproductive states.
We hypothesized that the relationship between lower
mood and lower sleep quality would strengthen during
and after the menopause, thereby partly explaining the
increase in mood and sleep symptoms typically found in
these periods. Mood was assessed not only with a con-
ventional total depression score, but also with a factorial
design for a detailed evaluation of the relationships in
order to identify specific subcategories, if any, of depres-
sive symptoms.
Methods
Subjects and study design
Altogether 61 women took part in the study: 11 younger
women (age range 20–26 years), 21 perimenopausal
women (age range 43–51 years) and 29 postmenopausal
women (age range 58–71 years). This study was a part of a
larger study investigating the effects of menopause on sleep
and cognition [35]. In order to avoid the possible confound-
ing effects of health-illness-related factors, healthy women
only were selected for the study. Younger women were re-
cruited via announcements at the University of Helsinki
and studied in the Sleep Research Unit of the Institute of
Biomedicine, University of Helsinki, Finland. The peri-
menopausal and postmenopausal women were enrolled
through announcements in the local newspapers in the area
of Turku and the studies were conducted in the Sleep Re-
search Unit of the University in Turku, Finland. The Turku
Sleep Research Unit served as the supervising and monitor-
ing unit of the study. Perimenopausal status was defined by
the serum follicle stimulating hormone (FSH) level
(<23 IU/mL) and an ongoing regular or irregular menstrual
cycle. Postmenopause was determined by age (≥58 years)
and at least 12 months of amenorrhea. None of the peri-
menopausal and postmenopausal women had used any
hormone therapy (HT) in at least 12 months prior to or
during the study, with the exception of one perimeno-
pausal woman, in whom the washout period was five
months. The younger women were all currently taking
oral contraceptives (OCs) (ethinyl estradiol 20 ug +
desogestrel 0.15 mg, Mercilon©, Organon, Oss, the
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were examined during the first days of their menstrual
cycle at the follicular phase.
Presence of a mental, cardiovascular (except drug-
treated balanced hypertension), endocrine (except drug-
treated balanced hyperlipidemia), pulmonary, neurological
or specific sleep disorder or malignancies was one of
the exclusion criteria. Also women suffering from other
conditions possibly affecting sleep (e.g. fibromyalgia or
anemia) were excluded. Other exclusion criteria included
the use of medication with central nervous system effects,
alcohol abuse, smoking and excessive caffeine intake
(>5 cups of coffee per day). All women had regular sleep-
wake schedules and normal levels of blood hemoglobin,
leucocytes, thrombocytes and serum thyrotropin. All
women gave written informed consent after oral and
written information. The study was approved by the
Ethics Committee of Turku University Hospital and the
University of Helsinki.
Mood and sleep assessments
The presence of current depressive symptoms was
assessed via the 21-item Beck Depression Inventory
(BDI) [36]. As the study sample consisted of healthy
women of different age ranges, in addition to consider-
ing the BDI total score, a factor analysis was performedTable 1 BDI factor analysis*
F1 F2
#1 sadness 0.099 0.44
#2 pessimism −0.027 0.03
#3 past failure 0.243 0.22
#4 loss of pleasure −0.178 0.98
#5 guilty feelings 0.390 0.17
#6 punishment feelings 0.928 0.28
#7 self-dislike 0.295 −0.07
#8 worthlessness −0.022 0.17
#10 crying 0.062 0.05
#11 irritability 0.012 0.20
#12 lost interest in people 0.168 0.37
#13 indecisiveness −0.033 0.13
#14 looking ugly 0.115 0.44
#15 impaired work capability 0.074 −0.14
#16 changed sleep pattern 0.153 0.08
#17 fatigue or tiredness 0.003 0.17
#18 lost appetite −0.033 −0.11
#20 worries about health 0.295 0.48
#21 lost interest in sex −0.077 0.37
Sumsqr 1.372 2.21
*Items with no (# 9: suicidal ideation) or one (# 19: weight loss) positive answer exc
Abbreviations: F1 punishment/guilty feelings, F2 dissatisfaction, F3 depressive-emotito identify the factors that could best explain the BDI
items (Cronbach’s alpha = 0.75) in the whole sample. Be-
cause depressive disorders are notoriously multidimen-
sional and characterized by different symptomatic
patterns according to a number of correlates (including
age and gender), a factor analysis was chosen as an ap-
proach to address depressive subcomponents. Four fac-
tors were identified and, on the basis of their most
weighted loadings, named as “punishment/guilty feelings”
(F1: guilty feelings, punishment feelings and self-dislike/
disappointment), “dissatisfaction” (F2: loss of pleasure,
worries about one’s health, feeling of looking ugly, sadness,
lost interest in people), “depressive-emotional” (F3: lost
appetite, crying, pessimism, sadness and feeling of worth-
lessness), and “depressive-somatic” (F4: indecisiveness,
changed sleep pattern, lost interest in sex, past failure, im-
paired working capability, tiredness and irritability) pat-
terns (Table 1). Items with no (#9: suicidal ideation) or
only one (#19: weight loss) positive answer were excluded
from the analyses.
Subjective insomnia (a sum score, with the range of
5–25) during the past three months was evaluated using
the Basic Nordic Sleep Questionnaire (BNSQ) [37], with
lower scores referring to lower levels of sleeping prob-
lems. The subjects kept a sleep diary during the three
weeks before and one week after the study to verify theirF3 F4 Sumsqr
5 0.304 0.268 0.372
2 0.306 0.213 0.141
4 0.039 0.493 0.354
0 0.025 −0.005 0.993
5 0.258 0.227 0.301
6 −0.005 −0.239 1.000
3 −0.034 0.199 0.133
2 0.289 0.147 0.135
1 0.322 −0.031 0.111
7 0.099 0.313 0.151
5 0.183 0.060 0.206
3 0.158 0.582 0.383
5 −0.019 0.238 0.269
9 −0.036 0.482 0.262
7 0.218 0.554 0.385
5 −0.105 0.476 0.269
0 0.984 −0.104 0.993
6 0.006 0.099 0.333
7 0.058 0.521 0.423
1 1.544 2.088
luded from the analysis. Weighted loadings at each factor in boldface.
onal symptoms, F4 depressive-somatic symptoms.
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schedules (10:00 – 11:00 pm to 6:00 – 7:00 am). The
women spent one adaptation night (7:30 pm – 8:00 am,
time in bed 11:00 pm – 7:00 am) in the sleep laboratory.
In the following morning, a venous blood sample was
taken for baseline serum FSH and estradiol (E2) mea-
surements. In the following evening, the women
returned to the laboratory at 7:30 pm for the baseline
sleep recording. The all-night polysomnography (PSG)
recordings consisted of continuous monitoring via elec-
troencephalograms (EEG), electro-oculograms (EOG), a
mandibular electromyogram (EMG) and an electrocar-
diogram (ECG, Embla®, Medcare Flaga hf. Medical de-
vices, Reykjavik, Iceland). Two EEG-channels (C3/A2,
C4/A1) were used in younger women, while four EEG-
channels (C3/A2, C4/A1, O1/A2 and O2/A2) were used
in perimenopausal and postmenopausal women. Sleep
stages were visually scored in 30-s epochs according to
conventional criteria [38] by the same scorer (NK) and
controlled by a senior scorer (PP-K). For the purpose of
this study, three groups of sleep variables were consid-
ered as follows.
1. general sleep: sleep latency (period from lights off to
sleep onset, defined as the appearance of three
consecutive epochs of S1 or the first epoch of any
other stage), total sleep time [sum of time spent in
Stage 1 (S1), Stage 2 (S2), SWS, REM sleep and
movement time (MT)], sleep efficiency (the
percentage of total sleep time out of time in bed)
and number of arousals (EEG α-activity for at least
three seconds [39]);
2. REM sleep: REM latency (the time from sleep onset
to the first 30 s of the REM stage), REM percentage
(the percentage of total time in bed, from lights off
to lights on) and REM awakenings (the number of
times entering wake stage from REM sleep);
3. SWS: SWS latency (the time from sleep onset to the
first 30 s of the SWS), SWS percentage (the
percentage of total time in bed, from lights off to
lights on), SWS awakenings (the number of times
entering wake stage from SWS) and total slow wave
activity in NREM-sleep (SWA, 0.75–4 Hz) [40].
Statistical analysis
One perimenopausal and one postmenopausal woman
were excluded from the analyses because of missing data.
The normality of the distributions was tested with the
Shapiro-Wilk test. Since the distributions of some variables
were skewed, non-parametric Kruskal-Wallis test was per-
formed to compare means between the three groups, using
reproductive state as grouping variable (younger, perimeno-
pausal or postmenopausal). When a significant difference
was found, the pair-wise differences between each groupwere tested with Student’s t-test (in the case of normal
distribution) or Mann–Whitney test, as appropriate. The
results were corrected according to the Bonferroni proced-
ure. A p-value of < 0.05 was considered significant.
A factor analysis was performed to identify the factors
that best explained the variability within the BDI items.
The factor matrix was computed according to the max-
imum likelihood principle and employing the algorithm
presented by Jöreskog [41]. The standard orthogonal
Varimax rotation was used to examine the degree of cor-
relation among factors. The reliability estimates were
computed according to the principles given by Cronbach
[42] and the general measurement framework introduced
by Tarkkonen [43] and developed further by Vehkalahti
[44] using the RELIAB module of the Survo MM pro-
gram [45].
Multivariable analysis was performed using generalized
linear models to test the associations between sleep vari-
ables vs. BDI total score and each of the identified BDI
factors. The analyses were performed separately on each
group. The results were further controlled for age. Data
were visually checked for outliers, defined as cases fall-
ing outside more than 1.5 times the interquartile range.
All the multivariable analyses were repeated after exclu-
sion of the identified outliers. Additionally, given the
possible bias brought by the well-known tight inter-
relationship between sleep and depressive symptoms,
multivariable analyses were repeated after exclusion of
the sleep-related items (#16 and #17) from computation
of the BDI total score. Descriptive and multivariable ana-
lyses were performed using SPSS/PASW software (ver-
sion 18.0) (SPSS Inc., Chicago, IL, USA).
Results
Background characteristics of the participants are reported
in Table 2. All the younger women had a BDI total score
lower than 10 (range 0–5), indicating no depressive symp-
toms; one perimenopausal woman (BDI = 11) and 6 post-
menopausal women had a BDI total score ranging between
10 and 18 (BDI = 10 in two, BDI = 11 in one, BDI = 13 in
two and BDI = 15 in one), indicating mild to moderate de-
pressive symptoms. Postmenopausal women had higher
mean BDI total score than younger women (6.3, SD 3.9 vs.
1.8, SD 1.7; p = 0.003), while no difference emerged be-
tween perimenopausal and younger women (4.1, SD 3.3 vs.
1.8, SD 1.7; p = 0.147), or between perimenopausal and
postmenopausal women (4.1, SD 3.3 vs. 6.3, SD 3.9; p =
0.147). The three groups differed in sleep as follows: when
comparing with either perimenopausal or postmenopausal
women, the younger women had longer total sleep time,
better sleep efficiency, a greater SWS percentage, higher
total SWA, less REM awakenings and less SWS awaken-
ings. They also had longer REM latency than postmeno-
pausal women. Additionally, younger women had lower
Table 2 Background characteristics of the participants
Younger (n =11) Perimenopausal (n = 20) Postmenopausal (n = 28)
mean (SD)
Age (years) 23.1 (1.6) 47.7 (2.3) 63.3 (3.6)
FSH (U/L) 3.8 (2.8) 10.6 (4.8) 76.2 (29.2)
E2 (pml/L) 91.8 (87.3) 327.2 (330.2) 31.2 (10.6)
BMI kg/m2 23.1 (3.1) 23.9 (2.4) 27.2 (4.2)
BDI score (total) 1.8 (1.7) 4.1 (3.3) 6.3 (3.9)
F1 punishment/guilty feelings −0.26 (0.08) 0.18 (1.26) 0.01 (1.0)
F2 dissatisfaction −0.48 (0.06) 0.04 (1.08) 0.10 (1.05)
F3 depressive-emotional symptoms 0.20 (1.64) −0.20 (0.14) 0.07 (1.07)
F4 depressive-somatic symptoms −0.62 (0.38) −0.21 (0.70) 0.38 (1.02)
Note: BDI = Beck depression inventory; BMI = body mass index; E2 = estradiol; FSH = follicle stimulating hormone.
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and postmenopausal women. Compared to perimenopausal
women, postmenopausal women had higher BNSQ insom-
nia score. Results of pair-wise comparisons of the sleep var-
iables in younger, perimenopausal and postmenopausal
women have been published earlier in detail [40]; see also
Additional file 1.
BDI factors and insomnia
Higher BDI total score was associated with higher BNSQ
insomnia score in perimenopausal women (B = 0.457; 95%
CI = 0.139 to 0.775; p = 0.005), also after controlling for age.
However, the significance was lost when the sleep-related
items (#16 and #17) were removed from the BDI total score
(B = 0.256; 95% CI = −0.017 to 0.530; p = 0.066). Higher
scores at the depressive-emotional pattern (p = 0.043 and
p = 0.011) in younger and perimenopausal women, at the
depressive-somatic pattern (p = 0.036) in perimenopausal
women, and at the punishment/guilty feelings factor (p =
0.010) in postmenopausal women were associated with
higher BNSQ insomnia score. All the associations were
maintained after removing of potential outliers. Further as-
sociations emerged after age adjustment: higher dissatisfac-
tion score (p = 0.023 and p = 0.042) was associated with
higher insomnia score in younger and perimenopausal
women, while the association with depressive-somatic
symptoms lost the significance (Table 3).
BDI factors and general sleep
In younger women higher BDI total score was associ-
ated with lower amount of arousals (B = −0.042; 95%
CI = −0.079 to −0.005; p = 0.026), and in perimeno-
pausal women with lower sleep efficiency (B = −0.159;
95% CI = −0.296 to −0.023; p = 0.022) and shorter total
sleep time (B = −0.033; 95% CI = −0.061 to −0.004; p =
0.024), also after controlling for age. The associations
with sleep efficiency (B = −0.097; 95% CI = −0.210 to0.016; p = 0.002) and total sleep time (B = −0.020; 95%
CI = −0.043 to 0.004; p = 0.100) in perimenopausal
women were lost after removing the sleep-related items
(#16 and # 17) from the BDI total score. In perimeno-
pausal women higher score at the depressive-somatic
pattern was associated with longer sleep latency (p =
0.032); however, the association was lost after control-
ling for age or after removing the outliers. No associa-
tions were found in postmenopausal women (Table 4).
However, when outliers were removed, significant asso-
ciations emerged between higher punishment/guilty
feeling scores and shorter sleep time (B = −0.012; 95%
CI = −0.021 to −0.003; p = 0.008) and lower sleep effi-
ciency (B = −0.058; 95% CI = −0.100 to −0.015; p =
0.008) in postmenopausal women.
BDI factors and REM sleep
Higher BDI total score associated with a greater REM
percentage in postmenopausal women (B = 0.301; 95%
CI = 0.049 to 0.553; p = 0.019) also after controlling for
age, while no associations were found in the other
groups. However, the association was lost when the sleep-
related items (#16 and #17) were removed from the
BDI total score (B = 0.214; 95% CI = −0.032 to 0.459;
p = 0.088). Lower scores at the punishment/guilty feelings
(p = 0.005), dissatisfaction (p < 0.001) and depressive-som-
atic pattern (p = 0.001) and higher score at the depressive-
emotional pattern (p = 0.002) were associated with higher
amount of REM awakenings in younger women. Higher
dissatisfaction (p = 0.017) score related to longer REM
latency in perimenopausal women. Higher scores at the
depressive-somatic pattern (p = 0.005) related to a greater
REM percentage in postmenopausal women (Table 5),
but the association was lost after removing of the
outliers. All the above-mentioned associations, with
the only exception of the one between lower score at
the depressive-somatic pattern and higher amount of
Table 3 Associations between BDI factors vs. subjective sleep quality (BNSQ insomnia)
Punishment/guilty feelings (F1) Dissatisfaction (F2) Depressive-emotional(F3) Depressive-somatic (F4)
B 95% CI p B 95% CI p B 95% CI p B 95% CI p
Younger women
BNSQ
insomnia
simple −0.005 −0.025 to
0.015
0.651 −0.011 −0.023 to
0.001
0.081 0.366
0.011 to
0.720
0.043 −0.039 −0.133 to
0.055
0.416
age-
adjusted −0.009
−0.028 to
0.011
0.385 −0.014
−0.025 to
−0.002 0.023 0.442
0.103 to
0.781
0.011 −0.059
−0.149 to
0.030
0.194
Perimenopausal women
BNSQ
insomnia
simple −0.062 −0.205 to
0.081
0.394 0.105
−0.011 to
0.221
0.077 0.018
0.004 to
0.032
0.011 0.078
0.005 to
0.151
0.036
age-
adjusted 0.046
−0.134 to
0.226
0.618 0.159 0.006 to 0.312 0.042 0.025
0.007 to
0.043
0.006 0.052
−0.045 to
0.149
0.296
Postmenopausal women
BNSQ
insomnia
simple 0.123 0.029 to
0.216
0.010 −0.054
−0.161 to
0.053
0.323 0.003
−0.109 to
0.115
0.955 0.088
−0.013 to
0.189
0.086
age-
adjusted 0.126
0.035 to
0.217
0.007 −0.056 −0.163 to
0.051
0.306 0.006
−0.104 to
0.117
0.913 0.086
−0.014 to
0.187
0.091
Associations between each BDI factor and BNSQ insomnia score were tested in each reproductive group separately via generalized linear models. Potential
outliers included in the models.
Significant items are in italic.
Note: BDI = Beck depression inventory; BNSQ = basic Nordic sleep questionnaire; 95% CI = 95% confidence intervals.
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after controlling for age.
BDI factors and SWS
No associations were found between BDI total score and
any of the SWS variables. However, in younger women
higher scores at the dissatisfaction (p = 0.001) and depres-
sive-somatic pattern (p = 0.025), and lower score at
the depressive-emotional pattern (p = 0.001) associated
with a greater SWS percentage. Moreover, lower scores at
the punishment/guilty feelings (p = 0.036), dissatisfaction
(p = 0.001) and depressive-somatic pattern (p = 0.009), and
higher score at the depressive-emotional pattern (p = 0.003)
associated with higher amount of SWS awakenings. Higher
score at the depressive-somatic pattern (p = 0.030) score
related to longer SWS latency in postmenopausal women
(Table 6). All the associations, except those of the depres-
sive-somatic pattern in younger women, maintained their
significance after controlling for age. When removing the
outliers, a higher score at punishment/guilty feelings, but
not at the depressive-somatic pattern, was associated with
longer SWS latency (B = 0.095; 95% CI = 0.035 to 0.155;
p = 0.002) in postmenopausal women.
(The associations between mood symptoms and sleep
quality in the three groups are illustrated in Additional
files 2: Figure S1, Additional file 3: Figure S2 and Additional
file 4: Figure S3).
Discussion
Associations between sleep stages or sleep quality and
the clinically subthreshold depressive symptoms wereevident both in perimenopausal and postmenopausal
women. Higher depression scores associated with a
lower subjective sleep quality (a higher insomnia score)
as well as a lower objective sleep quality (a lower sleep
efficiency and a shorter total sleep time), especially in
perimenopausal women. Also, postmenopausal women
with a higher BDI score had more REM sleep. On the
contrary, the total BDI score was not sensitive enough to
detect any significant associations with sleep in younger
women.
To identify specific subgroups of depressive symptoms,
factor analysis yielded a dual pattern of depression-with-
sleep associations in younger women with respect to the
SWS amount and SWS or REM awakenings: more
depressive-emotional symptoms were associated with a
smaller SWS percentage and with more SWS awakenings
and more REM sleep awakenings, whereas, vice versa, the
associations towards the opposite directions were found
concerning punishment, dissatisfaction and depressive-
somatic symptoms. In perimenopausal women more dissat-
isfaction was associated with a longer REM latency, and
more depressive-somatic symptoms with a worse sleep
quality (higher BNSQ score and longer sleep latency). In
addition, more depressive-somatic symptoms were associ-
ated with a greater REM percentage and a longer SWS la-
tency in postmenopausal women. When the outliers or the
sleep-related items (#16 and #17) were removed from the
analyses, most of the associations with depressive somatic
symptoms in perimenopausal and postmenopausal women
were lost; rather, more punishment/guilty feelings were
found to be associated with a worse sleep quality (higher
Table 4 Associations^ between BDI factors vs. general sleep variables
Punishment/guilty feelings
(F1) Dissatisfaction (F2)
Depressive-emotional
symptoms (F3)
Depressive-somatic
symptoms (F4)
B 95% CI p B 95% CI p B 95% CI p B 95% CI p
Younger women
Sleep latency
0.002
−0.003 to
0.007
0.374 0.002
−0.002 to
0.005
0.384 −0.035 −0.139 to
0.068
0.504 0.011
−0.012 to
0.035
0.346
Sleep efficiency
0.002
−0.007 to
0.010
0.672 0.001
−0.004 to
0.007
0.666 −0.039
−0.210 to
0.132
0.655 0.009
−0.030 to
0.049
0.644
Total sleep time
0.000
−0.001 to
0.002
0.687 0.000
−0.001 to
0.001
0.666 −0.008 −0.043 to
0.027
0.649 0.002
−0.006 to
0.010
0.655
Number of
arousals 0.000
−0.002 to
0.002
0.695 0.000
−0.001 to
0.002
0.675 −0.015 −0.056 to
0.027
0.487 −0.001 −0.011 to
0.009
0.863
Perimenopausal women
Sleep latency
−0.009
−0.044 to
0.026
0.611 −0.010
−0.039 to
0.020
0.521 0.001
−0.003 to
0.004
0.793 0.019 0.002 to 0.037 0.032
Sleep efficiency
−0.004
−0.063 to
0.055
0.896 −0.028
−0.077 to
0.022
0.276 −0.005
−0.011 to
0.001
0.075 −0.023
−0.054 to
0.009
0.159
Total sleep time −0.001 −0.013 to
0.012
0.905 −0.006 −0.016 to
0.005
0.295 −0.001 −0.002 to
0.000
0.082 −0.005 −0.011 to
0.002
0.155
Number of
arousals −0.002
−0.014 to
0.011
0.806 −0.005 −0.016 to
0.005
0.290 0.000
−0.001 to
0.001
0.823 0.005
−0.002 to
0.011
0.167
Postmenopausal women
Sleep latency
0.019
−0.006 to
0.043
0.135 −0.014
−0.041 to
0.012
0.281 0.016
−0.011 to
0.043
0.245 0.002
−0.024 to
0.028
0.865
Sleep efficiency −0.028 −0.059 to
0.003
0.079 0.014
−0.020 to
0.048
0.405 −0.020 −0.054 to
0.014
0.254 0.003
−0.030 to
0.037
0.843
Total sleep time −0.006 −0.012 to
0.001
0.080 0.003
−0.004 to
0.010
0.409 −0.004 −0.011 to
0.003
0.252 0.001
−0.006 to
0.008
0.845
Number of
arousals −0.001
−0.006 to
0.004
0.767 0.002
−0.003 to
0.008
0.399 −0.002
−0.008 to
0.003
0.432 −0.005
−0.010 to
0.000
0.068
Associations between each BDI factor and general sleep variables were tested in each reproductive group separately via generalized linear models. Potential
outliers included in the models.
Significant items are in italic.
^not age-adjusted.
Note: BDI = Beck depression inventory; 95% CI = 95% confidence intervals.
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http://www.biomedcentral.com/1471-244X/14/177scores of the subjective insomnia on BNSQ, a lower sleep
efficiency, a shorter total sleep time, and a longer SWS
latency) in postmenopausal women.
Previous studies focusing on the relationship between
mood and sleep have typically used either diagnostic cat-
egories or sum scores of different depression assessment
tools [46-49]. In the current study, we used the BDI total
score which, however, produced limited associations,
probably because of the generally good mental health
status of our participants. The total BDI score was a sen-
sitive enough index for detecting some previously re-
ported associations between mood and sleep [33],
especially in perimenopausal women, and to a lesser ex-
tent, in postmenopausal women. In specific, a relation-
ship with the subjective sleep quality, known to be
impaired in the context of depressive symptoms [33],
was evident only in perimenopausal women. Addition-
ally, a relationship between depressive symptoms and
impairment in the objective sleep quality emerged bothin perimenopausal (a shorter sleep time and a decreased
sleep efficiency) and postmenopausal (a greater REM
percentage) women, both findings being specific markers
for depression [18,33]. However, it is of note that these
associations lost their significance when the sleep-related
items (#16 and #17) were removed from the analyses,
further highlighting the tight inter-relationship between
objective sleep impairment and depressive symptoms, and
thus limiting any causal inference. The fact that the sig-
nificance was lost after removing the sleep-related items
may also suggest that the above-mentioned findings were
mainly expression of poor sleep rather than of a true asso-
ciation between poor sleep and depressive symptoms in
these reproductive groups.
The literature is rather consistent in reporting associa-
tions between depressive symptoms and sleep impairment
already in young age [50,51]. However, in our study only
one connection between the total BDI score and sleep was
found in younger women, where hypersomnia rather than
Table 5 Associations^ between BDI factors vs. REM sleep variables
Punishment/guilty feelings
(F1)
Dissatisfaction (F2) Depressive-emotional
symptoms (F3)
Depressive-somatic
symptoms (F4)
B 95% CI p B 95% CI p B 95% CI p B 95% CI p
Younger women
REM latency 0.001 0.000 to 0.002 0.145 0.001 0.000 to 0.001 0.178 −0.013 −0.039 to
0.012
0.316 0.004 −0.001 to 0.010 0.127
REM % −0.002 −0.014 to 0.009 0.689 0.000 −0.007 to 0.008 0.917 −0.045 −0.276 to
0.187
0.704 −0.007 −0.061 to 0.047 0.790
REM
awakenings
−0.047 −0.080 to
−0.014
0.005 −0.037 −0.056 to
−0.017
<0.001 1.005 0.357 to 1.652 0.002 −0.247 −0.391 to
−0.103
0.001
Perimenopausal women
REM latency 0.002 −0.015 to 0.020 0.787 0.016 0.003 to 0.030 0.017 0.001 0.000 to 0.003 0.148 −0.005 −0.015 to 0.004 0.290
REM % 0.036 −0.053 to 0.124 0.428 −0.026 −0.102 to 0.051 0.509 −0.004 −0.013 to
0.006
0.451 −0.019 −0.068 to 0.031 0.459
REM
awakenings
−0.188 −0.406 to 0.030 0.091 0.005 −0.195 to 0.204 0.961 −0.007 −0.032 to
0.018
0.568 −0.011 −0.140 to 0.118 0.865
Postmenopausal women
REM latency −0.001 −0.016 to 0.013 0.855 −0.008 −0.023 to 0.006 0.269 −0.001 −0.017 to
0.015
0.895 0.003 −0.012 to 0.018 0.713
REM % 0.004 −0.066 to 0.074 0.911 0.022 −0.052 to 0.095 0.558 0.038 −0.036 to
0.112
0.317 0.091 0.028 to 0.154 0.005
REM
awakenings
0.025 −0.092 to 0.143 0.672 0.064 −0.057 to 0.186 0.297 −0.052 −0.177 to
0.073
0.414 −0.076 −0.193 to 0.040 0.200
Associations between each BDI factor and REM sleep variables were tested in each reproductive group separately via generalized linear models. Potential outliers
included in the models.
Significant items are in italic.
^not age-adjusted.
Note: BDI = Beck depression inventory; 95% CI = 95% confidence intervals; REM = rapid eye movement.
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http://www.biomedcentral.com/1471-244X/14/177sleep impairment was connected with depressive symp-
toms. This could be due to the overall normal mood
and sleep quality in young women. Because of these lim-
ited findings, we further performed a factor analysis,
which grouped related BDI items into four specific cat-
egories with different depressive dimensions. As said,
this was done in an attempt to better identify the differ-
ent sub-components that are likely to characterize pau-
cisymptomatic depressed women at different age and
reproductive stages. When analyzing the associations
between the BDI factors and sleep, a dual pattern of
associations was consistently displayed in younger women:
either the one between the depressive-emotional factor
and more disrupted sleep, or that between punishment,
dissatisfaction and depressive-somatic factors and less
disrupted sleep. The depressive-emotional factor, which
included feelings of sadness, hopelessness and worthless-
ness, was associated with a smaller SWS percentage and
an increased number of awakenings from both SWS and
REM sleep. The other factors, i.e. punishment (including
also self-dislike), dissatisfaction (including loss of pleasure
and worries about health), and depressive-somatic (ex-
pression of functional impairment) symptoms, had these
associations in the opposite direction. Thus, it seemed
that the depressive-emotional factor revealed a findingtypical of depression, where depressed persons report
(and have) a reduced sleep quality or insomnia [14,21].
On the other hand, the other BDI factors were associated
with more hypersomnic features, suggesting that different
depressive symptoms may be related to different dimen-
sions of sleep impairment. In younger women more
REM awakenings were associated with more depres-
sive emotional symptoms, but with lower scores on
the other depressive factors. This apparent contradiction
could be explained by the fact that a high amount of REM
sleep and sleep fragmentation are specific markers for
depression. Emotional symptoms are likely to be the
main dimension of depression in younger women, while
other symptoms, including the somatic ones, are a
major depressive feature in older individuals [52,53]. In
this context, it is possible that the increased number of
awakenings from REM sleep, expression of more frag-
mented sleep, results associated with the most signifi-
cant depressive factor in young women (the emotional
dimension) rather than with the remaining dimensions.
This would be in line with the cognition of a tight inter-
relation between sleep (in particular REM sleep) and the
emotional processing [54]. Another possible explanation
to the apparent better sleep quality in relation to pun-
ishment, dissatisfaction and depressive-somatic factors
Table 6 Associations^ between BDI factors vs. SWS variables
Punishment/guilty feelings
(F1)
Dissatisfaction (F2) Depressive-emotional
symptoms (F3)
Depressive-somatic
symptoms (F4)
B 95% CI p B 95% CI p B 95% CI p B 95% CI p
Younger women
SWS latency 0.000 −0.008 to 0.008 0.936 −0.001 −0.006 to 0.005 0.827 0.024 −0.142 to 0.189 0.778 0.000 −0.039 to 0.039 0.997
SWS % 0.011 −0.002 to 0.023 0.093 0.012 0.005 to 0.018 0.001 −0.344 −0.542 to
−0.147
0.001 0.062 0.008 to 0.117 0.025
SWS
awakenings
−0.106 −0.205 to
−0.007
0.036 −0.096 −0.152 to
−0.040
0.001 2.701 0.913 to 4.490 0.003 −0.585 −1.024 to
−0.146
0.009
SWA total 0.000 −0.001 to 0.000 0.455 0.000 0.000 0.697 0.000 0.000 0.477 −0.001 −0.003 to 0.001 0.464
Perimenopausal women
SWS latency −0.009 −0.041 to 0.023 0.580 −0.017 −0.044 to 0.009 0.196 −0.002 −0.005 to 0.001 0.262 0.003 −0.014 to 0.021 0.697
SWS % −0.022 −0.117 to 0.073 0.656 0.028 −0.052 to 0.109 0.492 0.005 −0.005 to 0.015 0.338 0.020 −0.032 to 0.072 0.442
SWS
awakenings
−0.069 −0.437 to 0.299 0.714 0.052 −0.264 to 0.367 0.749 0.015 −0.025 to 0.054 0.467 0.107 −0.092 to 0.306 0.292
SWA total −0.002 −0.008 to 0.003 0.441 −0.002 −0.007 to 0.003 0.396 0.000 −0.001 to 0.000 0.188 −0.001 −0.004 to 0.002 0.542
Postmenopausal women
SWS latency 0.015 −0.007 to 0.037 0.181 −0.009 −0.033 to 0.014 0.427 0.001 −0.023 to 0.025 0.940 0.024 0.002 to 0.045 0.030
SWS % −0.026 −0.075 to 0.024 0.305 0.006 −0.047 to 0.058 0.835 −0.030 −0.083 to 0.023 0.271 −0.040 −0.089 to 0.010 0.115
SWS
awakenings
−0.147 −0.359 to 0.065 0.174 0.044 −0.185 to 0.273 0.708 −0.025 −0.210 to 0.260 0.833 −0.168 −0.383 to 0.046 0.124
SWA total −0.009 −0.021 to 0.002 0.122 0.002 −0.010 to 0.015 0.703 −0.009 −0.021 to 0.004 0.185 −0.009 −0.021 to 0.003 0.133
Associations between each BDI factor and SWS variables were tested in each reproductive group separately via generalized linear models. Potential outliers
included in the models.
Significant items are in italic.
^not age-adjusted.
Note: BDI = Beck depression inventory; 95% CI = 95% confidence intervals; SWA = slow wave activity SWS = slow wave sleep.
Toffol et al. BMC Psychiatry 2014, 14:177 Page 9 of 13
http://www.biomedcentral.com/1471-244X/14/177in younger women might be that they have retained the
ability to cope with depressive symptoms through im-
proving their sleep quality. This hypothesis is partly sup-
ported by the findings by Talamini et al. [55]. In a sample
of young healthy individuals (mean age 20 years, 72%
women) the authors found a bimodal pattern of response
to an externally induced distress in terms of sleep quality.
They concluded that, due to individual differences, some
subjects may respond adaptively, i.e. improving their
quality of sleep, while other individuals may respond in a
maladaptive manner, i.e. with a reduction of their sleep
quality. Based on their results, the authors suggested that
a high SWS percentage may be associated with higher
levels of “emotional dissipation” during sleep, while an
increased number of awakenings to poor emotional dissi-
pation. This is partly in line with our findings, where
more (REM and SWS) awakenings and a smaller
SWS percentage were related to higher emotional de-
pressive symptoms, but lower scores on other depressive
dimensions.
As sleep and its quality are known to deteriorate with
age (including aging of the hypothalamus-pituitary-
ovarian system, i.e. with the transition into menopause),
it can be hypothesized that this ability also deteriorateswith, or is altered by aging. In fact, this dual pattern in
the depression-sleep associations was not found among
perimenopausal or postmenopausal women. It is there-
fore possible that these different patterns of associations
reflect different symptomatic dimensions of depression
at different ages. Based on our results, it seems that the
emotional dimension is especially relevant in younger
women, while the somatic component is transiently more
evident in the perimenopausal group, and the affective
dimension more specifically related to punishment and
guilty feelings becomes relevant in postmenopausal women.
However, as mentioned above, in this study the younger
women in particular had low BDI scores, suggesting very
limited and mild depressive symptoms. However, even sub-
threshold depression is known to be associated with a poor
quality of life [56], and adolescents with subthreshold
depressive conditions have not only an impaired function-
ing and higher levels of suicidality [57], but also a high risk
of developing a major depressive episode [58].
Only in perimenopausal women, a connection between
more dissatisfaction and a longer REM latency was
found. This is partly in line with previous findings of a
prolonged sleep latency in depressed subjects [14]. Dur-
ing the perimenopausal period women are prone to
Toffol et al. BMC Psychiatry 2014, 14:177 Page 10 of 13
http://www.biomedcentral.com/1471-244X/14/177experience a variety of depressive and somatic symptoms
[59-61] that may equally belong to the four different
BDI factors identified in our study. Therefore, the total
BDI score was more sensitive in identifying the associa-
tions with impaired sleep quality. In addition, a mismatch
between subjective and objective sleep impairment in as-
sociation with depressive symptoms and disorders has
been reported during the menopausal transition, when the
common report of sleep complaints and dissatisfaction
with sleep not necessarily correlates with objective sleep
impairment [62]. Furthermore, factors other than depres-
sion may have a more significant role in causing the sleep
impairment typical for the perimenopausal period. For
instance, gradually decreasing female sex hormone levels
may directly affect sleep [63], and climacteric vasomotor
symptoms are known to be associated with sleep impair-
ment [30,32,64-67], independently of mood symptoms. In
fact, not only depressive symptoms but also depressive
disorders in perimenopausal and postmenopausal women
could be due to the vasomotor climacteric symptoms,
which impair sleep quality and quality of life in general,
resulting in compromised psychological well-being and
depression [68]. However, it is of note that some studies
have found an antidepressant effect of hormone therapy
in menopausal women irrespective of their vasomotor
symptoms [69].
In our sample of postmenopausal women higher depres-
sive-somatic symptoms were associated with more REM
sleep and a longer SWS latency. Somatic complaints, which
may in turn induce depression and impaired sleep, become
more frequent with age, especially in women. Women
complain more often than men about somatic symptoms
associated with psychological distress [70], and the rates of
“somatic depression”, albeit low, are higher in women than
in men [70,71]. As previously mentioned for the perimeno-
pausal women, vasomotor symptoms tend to be associated
with both depression and sleep disturbances [30,32,72] and
may account for this finding. These associations with
the depressive-somatic dimension were lost after re-
moving the cases with more extreme values, this sug-
gesting that the outliers in our sample, in alternative to
being a mere cause of statistical noise, represented a
subgroup of postmenopausal women suffering from
some degree of residual climacteric (including depres-
sive and somatic) symptoms. In addition, when excluding
the outliers from the analyses, the mismatch between
subjective and objective sleep impairment in association
with depressive symptoms became even less evident in
postmenopausal women, when more severe affective
symptoms specifically related to guilty and punish-
ment feelings associated with both impaired subjective
(BNSQ insomnia) and objective (lower sleep efficiency,
shorter total sleep time and longer SWS latency) sleep
quality.It warrants attention that the significance of the asso-
ciations with the depressive-somatic pattern in perime-
noapusal and postmenopausal women has to be
interpreted with caution. In fact, the BDI sleep-related
items (#16 and #17) were found to most markedly load
at the depressive-somatic factor in our model; therefore,
it cannot be ruled out that these findings are again
mainly expression of poor sleep in perimenopausal and
postmenopausal women. However, items other than the
sleep-related ones (e.g., the lost interest in sex) remark-
ably contributed to the depressive-somatic pattern in the
factor analysis, which could in fact account for the asso-
ciations detected in the perimenopausal and postmeno-
pausal groups.
It warrants attention that all the younger women in
our sample were taking OCs, and therefore, it is not pos-
sible to rule out that our results are biased by the effect
of hormonal contraception. Indeed, even though a num-
ber of studies have found no difference in terms of the
subjective sleep quality between naturally cycling women
and OC users [73,74], a modulation of sleep architecture
by OC use has been shown [73-77]. Sleep alterations,
such as a reduced sleep latency [77], and specifically a
short REM sleep latency [31,74,76], a decrease in SWS
[73-75] but an increase in stage 2 [73] and in REM sleep
[77], reduced arousals and a tendency towards a better
sleep efficiency [31,78] have been reported. Burdick and
colleagues [77] reported that both depressed and healthy
OC users had a shorter REM latency and less SWS than
non-users. Moreover, healthy OC users, but not the de-
pressed ones, had a shorter sleep latency and a
greater REM percentage than non-users [77]. On the
other hand, OC use may itself be associated with adverse
effects on mood in a subgroup of vulnerable women
[79,80], and they are a common cause of OC discontinu-
ation as well.
One of the limitations of this study is the small sample
size. However, the numbers are in line with those of other
studies on the same topic. Second, the study was carried
out on a selected healthy population, thus preventing the
generalization of the results to the general population. As
women with previous mental disorders, such as depressive
disorders, were excluded, our results cannot be extended to
hold for depressed patients. In addition, the associations be-
tween sleep and depressive symptoms were limited, as only
a minority of the study participants suffered from mild to
moderate depressive symptoms; for this reason, it is plaus-
ible that some of our findings were in fact driven by the
sleep symptoms themselves. However, given that the BDI
sleep-related items loaded mostly at the somatic factor
identified in our model, this limitation potentially concerns
only the associations with the depressive-somatic pattern in
perimenopausal and postmenopausal women. The charac-
teristics of our study sample (a small sample, with a wide
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http://www.biomedcentral.com/1471-244X/14/177age range, that was screened for psychiatric illness and that
reported few depressive symptoms) limit the applicability of
the derived BDI factors to other (general and clinical) popu-
lations. Because of the recruitment criterion of three differ-
ent reproductive states, the women also belonged to three
different age groups. Hence, we were not able to clearly dis-
entangle the effect of age from the effect of reproductive
state on mood and sleep. However, after controlling for age
within each reproductive group, part of the age effect could
be taken into account. Even though we could not control
for other confounding factors (e.g. stressful life events), the
strict exclusion criteria allowed us to minimize the effects
of factors such as irregular sleep-wake schedules, use of HT
and other medications, smoking, and use of alcohol or
drugs. Even though the state of mood and insomnia were
assessed with a self-administered tool, nevertheless, the val-
idity and reliability of the BDI and of the BNSQ scale has
been widely demonstrated [37,81]. Furthermore, using the
factor analysis procedure allowed us to better identify the
associations that would have not emerged, if only the total
BDI score was considered. Finally, the use of PSGs allowed
us to specifically assess the objective sleep quality.
Conclusions
Our results support the evidence of a relationship be-
tween mood and sleep, with more severe depressive
symptoms being linked to sleep impairment. The notable
implication of our study is that when depressive symp-
toms are mild, the BDI total score may not be able to
detect subtle connections. In these cases, a more de-
tailed factor analysis may offer a valuable analytical tool.
Moreover, the reproductive state should be taken into
account when evaluating the effect of depression on
sleep, since different related depression clusters may be
relevant.
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